Leaman John Harold 4
4 · IMPEL PHARMACEUTICALS INC · Filed Feb 16, 2023
Insider Transaction Report
Form 4
Leaman John Harold
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-14+70,000→ 70,000 totalExercise: $2.29Exp: 2033-02-13→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]The option vests as to 2.0833% of the total shares on March 14, 2023 and then 2.0833% of the total shares vests monthly thereafter, with 100% of the total shares vested and exercisable on February 14, 2027, subject to the reporting person's provision of service to the issuer on each vesting date.